Dr. Manel Juan:" “There are no good vaccines or bad vaccines”
Interview with Dr. Manel Juan, head of the Immunology Service
Service News from Inmunología
AEMPS authorises Hospital Clínic's CAR-T ARI-0001 for patients with acute lymphoblastic leukaemia
The Spanish Agency of Medicines and Medical Devices (AEMPS) has approved CAR-T ARI-0001, developed by Hospital Clínic, as and advanced therapy drug of...
Can you be protected against COVID-19 without antibodies?
In just a few months, the coronavirus has gone from being completely unknown to being the focus of countless scientific investigations around the world....
Immuneel Therapeutics, Hospital Clínic de Barcelona & IDIBAPS Announce a Strategic collaboration & a License Agreement
Immuneel Therapeutics Private Limited (Immuneel) today announced that it has entered into a multi-asset collaboration and licensing agreement with Hospital...
A consortium of European hospitals led by Clínic IDIBAPS is launching a cellular immunotherapy project to tackle COVID-19 with the support of Cellnex Telecom
Hospital Clínic de Barcelona-IDIBAPS and Cellnex have today signed an agreement to launch a multicentre research project that will allow better understanding...
A new cancer immune therapy spin-off of Hospital Clínic-IDIBAPS secures a 1.5 million-euro investment from Invivo Ventures
Hospital Clínic – IDIBAPS (Barcelona) has founded Gyala Therapeutics, a new spin-off company focused on developing new CAR-T therapies for treating hematological...
Evolution of cancer immunotherapy: from bone marrow transplant to CAR
The latest advance in the field of immune therapies against cancer are the active and targeted CAR therapies. This treatment consists of obtaining the...